Skip to main content
headshot of Andrew Lunn

Dr Andrew Lunn

School of Pharmacy and Biomedical Sciences

Dr Andrew Lunn is a pharmaceutics Lecturer in the School of Pharmacy and Biomedical Sciences. He completed his MPharm degree at Liverpool John Moores' School of Pharmacy in 2012 and his pre-registration training at Imperial College Hospital. He then went on to complete an MSc and PhD in Chemistry at Warwick University. His PhD focussed on the synthesis and biological interactions of glycopolymer nanoparticles, and their use in the targeted delivery of antibiotics. His interests now focus on teaching research in the Pedagogical Interest Group.

Andrew teaches mainly in the first two years of the pharmacy course, focusing on teaching the basic scientific principles underlying formualtion in an integrated fasion with practice. His reasearch now focusses on pedagogy, and he is the co-lead of the universities Pedagogy Interest Group (PIG). He also published multiple articles from his PhD work on the synthesis of glycopolymer nanoparticles and their use to taget antibiotics to intracellular tubeculosis.

Dr Andrew Lunn is a Lecturer in Pharmaceutics in the School of Pharmacy and Biomedical Sciences, with experience in both hospital and community pharmacy, and an interest in quantitatively studying how to improve teaching practices. He graduated from the Liverpool John Moores School of Pharmacy in 2012 with an MPharm degree, and then completed his pre-registration year at Imperial College Hospital including various clinical and non-clinical rotations. His PhD focussed on the synthesis of investigative glycopolymer nanoparticles via RAFT emulsion polymerisation, and more scalable equivalents using variations upon traditional emulsion polymerisation. The systems produced were used to probe the biological interactions of glycopolymers with lectins and applied to deliver antibiotics in a targeted responsive manner to mycobacteria infected macrophages. His current research focus is pedagogical having co-founded the Pedagogical Interest Group (PIG). His current active projects include: science integration of pharmacy labs, patients as teachers, undergraduate research and how idea density affects learning in students and patients with dementia. Andrew is a GPhC registered pharmacist and a member of the Royal Pharmaceutical Society and the UK and Ireland controlled release society. He is also an associate member of the Royal Society of Chemistry. He works to deliver truly integrated pharmacy teaching with expertise in chemistry, pharmaceutics and practice.